12 completed, 2 unknown. 4 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Rotavirus Vaccines: new trials by email Literature Review of Rotavirus Vaccines trials Research Report on Rotavirus Vaccines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage Vaccine - Rotavirus Gastroenteritis, Rotavirus Vaccines | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1600 | 2021-05-04 | 2025-03-18 | |
| Using "Decision Aids" to Help the Infant Family to Decide the Use of Oral Rotavirus Vaccine Decision aids - Rotavirus Vaccines | Not applicable | Unknown | Taipei Medical University Shuang Ho Hospital | 180 | 2019-01-25 | 2019-01-15 |
| Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried), Placebo - Rotavirus Infections, Rotavirus Vaccines | Phase 3 | Completed | Limited Liability Company Pharm Aid | 40 | 2018-06-25 | 2021-09-08 |
| This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine Rotarix, Pediarix, Hiberix - Rotavirus Infection, Rotavirus Vaccines | Phase 3 | Completed | GlaxoSmithKline | 1280 | 2017-09-14 | 2020-12-29 |
| Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks HRV PCV-free liquid vaccine, Rotarix - Infections, Rotavirus, Rotavirus Vaccines | Phase 3 | Completed | GlaxoSmithKline | 1612 | 2016-10-27 | 2020-07-21 |
| Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis Data collection - Infections, Rotavirus, Rotavirus Vaccines | Completed | GlaxoSmithKline | 5394 | 2012-11-27 | 2019-05-30 | |
| Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure Rotarix - Intestinal Failure, Rotavirus Vaccines | Phase 4 | Completed | Seattle Children's Hospital | 15 | 2009-12-01 | 2015-11-18 |
| Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants Rotarix ™, Placebo - Infections, Rotavirus, Rotavirus Vaccines | Phase 4 | Completed | GlaxoSmithKline | 684 | 2009-08-25 | 2020-01-18 |
| Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea Gastroenteritis, Rotavirus Vaccines | Unknown | Yonsei University | 200 | 2008-05-01 | 2009-02-19 | |
| Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children Sample collection - Infections, Rotavirus, Rotavirus Vaccines | Completed | GlaxoSmithKline | 643 | 2008-02-23 | 2020-01-03 | |
| Intussusception Surveillance After Rotarix Introduction in Mexico Hospital log review. - Intussusception (IS), Rotavirus Vaccines | Completed | GlaxoSmithKline | 786 | 2008-01-01 | 2012-03-19 | |
| Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants Rotarix, Placebo - Infections, Rotavirus, Rotavirus Vaccines | Phase 3 | Completed | GlaxoSmithKline | 765 | 2007-06-19 | 2020-01-02 |
| A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. Rotarix™, Placebo - Infections, Rotavirus, Rotavirus Vaccines | Phase 2 | Completed | GlaxoSmithKline | 375 | 2007-03-09 | 2020-01-02 |
| To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination Rotarix, Data collection - Infections, Rotavirus, Rotavirus Vaccines | Completed | GlaxoSmithKline | 1439 | 2006-11-16 | 2021-03-16 |
Rotavirus Infections (9) · Gastroenteritis (5) · Diarrhea, Infantile (1) · Intestinal Failure (1) · Intussusception (1) · Tooth, Impacted (1)
Infections (9) · RNA Virus Infections (9) · Reoviridae Infections (9) · Virus Diseases (9) · Digestive System Diseases (7) · Gastrointestinal Diseases (7) · Intestinal Diseases (2) · Diarrhea (1) · Intestinal Obstruction (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Stomatognathic Diseases (1) · Tooth Diseases (1)
RIX4414 vaccine (8) · Data Collection (2) · 13-valent pneumococcal vaccine (1) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Decision Support Techniques (1) · Freeze Drying (1) · Hepatitis B Vaccines (1) · Hiberix (1) · PEDIARIX (1) · Poliovirus Vaccine, Inactivated (1) · Specimen Handling (1) · Tetanus Toxoid (1) · Vaccines (1) · Vaccines, Attenuated (1)
GlaxoSmithKline (9) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Limited Liability Company Pharm Aid (1) · Seattle Children's Hospital (1) · Taipei Medical University Shuang Ho Hospital (1) · Yonsei University (1)
Japan (3) · South Korea (3) · United States (3) · Philippines (2) · Taiwan (2) · Belgium (1) · Costa Rica (1) · Finland (1) · Germany (1) · Ghana (1) · Mexico (1) · Russia (1) · Spain (1) · Zambia (1)
Dong Soo Kim, MD, PhD (1) · Irina V. Feldblium, Dr. Sci (1) · Janet Englund, MD (1) · Patrick J Javid, MD (1) · Sheng-Chieh Lin, MD (1) · Simon Horslen, M.B., ChB (1)
2015 (3), 2016 (2)